Search company, investor...

BioResonator

bioresonator.se

Founded Year

2000

Stage

Other Investors | Alive

About BioResonator

BioResonator aims to measure eye pressure with the resonance frequency.

Headquarters Location

Tvistevagen 48

907 19,

Sweden

Missing: BioResonator's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BioResonator's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

BioResonator Patents

BioResonator has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/6/2005

1/12/2010

Kidney diseases, Sensors, Fluid dynamics, Nephrology, Quantized radio modulation modes

Grant

Application Date

4/6/2005

Grant Date

1/12/2010

Title

Related Topics

Kidney diseases, Sensors, Fluid dynamics, Nephrology, Quantized radio modulation modes

Status

Grant

BioResonator Frequently Asked Questions (FAQ)

  • When was BioResonator founded?

    BioResonator was founded in 2000.

  • What is BioResonator's latest funding round?

    BioResonator's latest funding round is Other Investors.

  • Who are the investors of BioResonator?

    Investors of BioResonator include Linkmed, Norrlandsfonden and Karolinska Development.

  • Who are BioResonator's competitors?

    Competitors of BioResonator include eSight, Senseonics, Powervision, TearScience, TruTouch Technologies, EyeTechCare, Third Eye Diagnostics, Eyesense, FlowCardia, Ocusciences and 12 more.

Compare BioResonator to Competitors

A
Anaemedia

AnaeMedia is a socio-technological initiative. The company have developed a prick-less anaemia scanner that can measure HB levels and help diagnose anaemia by referring to an accompanying simple chart.

Ocusciences Logo
Ocusciences

OcuSciences is developing a product to use images from the eye to detect diseases such as diabetes at an earlier stage.

R
RealisticEye

Realistic Eye aims to provide a more natural appearance for the 750,000 patients in the US with an artificial eye that does not dilate and therefore appears unnatural. RealisticEye achieves these results by introducing a dilating artificial eye.

eSight Logo
eSight

eSight creates electronic glasses that restore or enhance sight for individuals living with vision loss. Worn comfortably like a normal pair of glasses or with prescription lenses built-in, they allow a person with low vision to see in virtually the same manner as someone who is fully-sighted can. The company's SPEX enhances vision for precision tasks, allowing users to pan and zoom the real world or streamed images, and brings critical information to the point of task without overwriting or obstructing natural vision for full situational awareness and mobility.

L
Lumineyes

Lumineyes uses a laser to heat the pigment layer of their eye to allow people with brown eyes to turn them permanently green or blue.

V
Vast Audio

VAST Audio leverages its acoustics platform technology to develop DSP technologies involving the application of advanced sensory processing techniques to 3D hearing devices. The Company is developing a spatial hearing aid to effectively support listening in both noisy and quiet environments. The hearing aid is based on the company's Completely-in-Canal (CIC) earphone and aims to provide the perceptual basis for segregating talkers in noisy environments and will lead to vast improvement in speech segregation and intelligibility.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.